Phantom Neuro: Bridging the Gap Between Mind and Machine
April 20, 2025, 3:32 pm
Location: United States, Texas, Austin
Employees: 11-50
Founded date: 2020
Total raised: $28.26M
In the realm of technology, the line between human capability and machine efficiency is becoming increasingly blurred. Phantom Neuro, a neurotechnology company based in Austin, Texas, is at the forefront of this evolution. Recently, the company secured $19 million in a Series A funding round, a significant leap towards enhancing human-machine interfaces. This funding, led by Ottobock, a giant in the prosthetics industry, is not just a financial boost; it’s a testament to the potential of merging neuroscience with robotics.
Phantom Neuro’s mission is clear: to develop a minimally invasive neural interface that allows for intuitive control of prosthetic limbs and robotic exoskeletons. Imagine a world where amputees can move robotic arms as naturally as their own. This is not science fiction; it’s the vision that Phantom Neuro is bringing to life with its flagship product, the Phantom X.
The recent funding round attracted a diverse group of investors, including Breakout Ventures, Draper Associates, and new players like Actual VC and METIS Innovative. This influx of capital brings Phantom Neuro’s total funding to $28 million, enabling the company to push forward with preclinical testing and first-in-human trials. The funds will also support regulatory submissions, paving the way for broader applications beyond prosthetics.
The significance of this funding cannot be overstated. It represents a pivotal moment in the company’s journey. With the backing of Ottobock, Phantom Neuro gains not only financial support but also invaluable expertise in the prosthetics market. Ottobock’s experience in restoring mobility to millions provides a solid foundation for Phantom Neuro’s commercialization efforts. This partnership is a powerful reminder of how collaboration can accelerate innovation.
Phantom Neuro’s technology is built on the foundation of neuroscience. The company’s ASCENT study demonstrated an impressive 94% accuracy in decoding real-time gestures across 11 essential hand and wrist movements. This level of precision is crucial for restoring function and independence to individuals with mobility impairments. It’s not just about creating a device; it’s about creating a seamless extension of the human body.
The implications of this technology extend far beyond prosthetics. As the company continues to develop its platform, the potential applications in robotics and assistive devices are vast. Imagine exoskeletons that allow individuals with mobility challenges to walk again or robotic arms that respond to thought. The future is bright, and Phantom Neuro is leading the charge.
The funding also highlights a growing trend in the convergence of neurotechnology, prosthetics, and robotics. As these fields intertwine, the possibilities for innovation expand. The collaboration between Phantom Neuro and Ottobock is a prime example of how different sectors can come together to create groundbreaking solutions. This partnership is not just about business; it’s about transforming lives.
As Phantom Neuro moves forward, the company faces the challenges that come with rapid growth. Preclinical testing and regulatory approvals are critical steps that require meticulous planning and execution. However, with a strong team led by CEO Dr. Connor Glass, the company is well-equipped to navigate these hurdles. Dr. Glass’s vision for the future of assistive technology is not just ambitious; it’s rooted in a deep understanding of the needs of individuals with mobility impairments.
The road ahead is filled with potential. The funding will enable Phantom Neuro to expand its research and development efforts, exploring broader control applications. This could lead to advancements in various fields, from rehabilitation to everyday assistive devices. The goal is to create technology that not only enhances physical capabilities but also enriches the quality of life for users.
In a world where technology often feels disconnected from humanity, Phantom Neuro is a beacon of hope. The company’s commitment to developing intuitive, user-friendly interfaces is a step towards a future where machines and humans work in harmony. This vision aligns with the growing demand for assistive technologies that empower individuals rather than hinder them.
As the narrative of Phantom Neuro unfolds, it serves as a reminder of the power of innovation. The convergence of neurotechnology and robotics is not just a trend; it’s a revolution. With each milestone, Phantom Neuro is not only advancing its technology but also redefining what it means to be human in an increasingly mechanized world.
In conclusion, Phantom Neuro’s recent funding round is more than just a financial achievement; it’s a significant step towards a future where technology enhances human capability. With the support of Ottobock and a robust network of investors, the company is poised to make a lasting impact on the lives of individuals with mobility impairments. The journey is just beginning, and the possibilities are limitless. As we look ahead, one thing is clear: the future of human-machine interaction is bright, and Phantom Neuro is leading the way.
Phantom Neuro’s mission is clear: to develop a minimally invasive neural interface that allows for intuitive control of prosthetic limbs and robotic exoskeletons. Imagine a world where amputees can move robotic arms as naturally as their own. This is not science fiction; it’s the vision that Phantom Neuro is bringing to life with its flagship product, the Phantom X.
The recent funding round attracted a diverse group of investors, including Breakout Ventures, Draper Associates, and new players like Actual VC and METIS Innovative. This influx of capital brings Phantom Neuro’s total funding to $28 million, enabling the company to push forward with preclinical testing and first-in-human trials. The funds will also support regulatory submissions, paving the way for broader applications beyond prosthetics.
The significance of this funding cannot be overstated. It represents a pivotal moment in the company’s journey. With the backing of Ottobock, Phantom Neuro gains not only financial support but also invaluable expertise in the prosthetics market. Ottobock’s experience in restoring mobility to millions provides a solid foundation for Phantom Neuro’s commercialization efforts. This partnership is a powerful reminder of how collaboration can accelerate innovation.
Phantom Neuro’s technology is built on the foundation of neuroscience. The company’s ASCENT study demonstrated an impressive 94% accuracy in decoding real-time gestures across 11 essential hand and wrist movements. This level of precision is crucial for restoring function and independence to individuals with mobility impairments. It’s not just about creating a device; it’s about creating a seamless extension of the human body.
The implications of this technology extend far beyond prosthetics. As the company continues to develop its platform, the potential applications in robotics and assistive devices are vast. Imagine exoskeletons that allow individuals with mobility challenges to walk again or robotic arms that respond to thought. The future is bright, and Phantom Neuro is leading the charge.
The funding also highlights a growing trend in the convergence of neurotechnology, prosthetics, and robotics. As these fields intertwine, the possibilities for innovation expand. The collaboration between Phantom Neuro and Ottobock is a prime example of how different sectors can come together to create groundbreaking solutions. This partnership is not just about business; it’s about transforming lives.
As Phantom Neuro moves forward, the company faces the challenges that come with rapid growth. Preclinical testing and regulatory approvals are critical steps that require meticulous planning and execution. However, with a strong team led by CEO Dr. Connor Glass, the company is well-equipped to navigate these hurdles. Dr. Glass’s vision for the future of assistive technology is not just ambitious; it’s rooted in a deep understanding of the needs of individuals with mobility impairments.
The road ahead is filled with potential. The funding will enable Phantom Neuro to expand its research and development efforts, exploring broader control applications. This could lead to advancements in various fields, from rehabilitation to everyday assistive devices. The goal is to create technology that not only enhances physical capabilities but also enriches the quality of life for users.
In a world where technology often feels disconnected from humanity, Phantom Neuro is a beacon of hope. The company’s commitment to developing intuitive, user-friendly interfaces is a step towards a future where machines and humans work in harmony. This vision aligns with the growing demand for assistive technologies that empower individuals rather than hinder them.
As the narrative of Phantom Neuro unfolds, it serves as a reminder of the power of innovation. The convergence of neurotechnology and robotics is not just a trend; it’s a revolution. With each milestone, Phantom Neuro is not only advancing its technology but also redefining what it means to be human in an increasingly mechanized world.
In conclusion, Phantom Neuro’s recent funding round is more than just a financial achievement; it’s a significant step towards a future where technology enhances human capability. With the support of Ottobock and a robust network of investors, the company is poised to make a lasting impact on the lives of individuals with mobility impairments. The journey is just beginning, and the possibilities are limitless. As we look ahead, one thing is clear: the future of human-machine interaction is bright, and Phantom Neuro is leading the way.